FDA Investigator Dr. Yubing Tang

Dr. Yubing Tang has inspections in 4 countries as of 31 Oct 2023. Dr. Yubing Tang has collaborated with a combinined 1508 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
31 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, China, Spain, Canada
Alice S Tsao, Alison N Stieg, Amy M Cramer, Anita R Michael, Barbara A Gullick, Bijoy Panicher, Bijoy Panicker, Brooke K Higgins, Cedar H Boakye, Chaltu N Wakijra, Charles D Brown, Chiang Syin, PhD, Christina K Theodorou, Christine I Shaw, Christopher R Czajka, Christopher T Middendorf, Claire M Minden, Daniel L Zheng, David A Oluwo, David J Hafner, Douglas A Campbell, Dr. Dominick Roselle, Dr. Roslyn F Powers, Edmund F Mrak, Jr, Emest F Bizjak, Erik W Koester, Erk W Koester, Frederick Razzaghi, George Pyramides, Hector J Colon Torres, James M Mason, James M Simpson, James Norman, Jonah S Ufferfilge, Jonah Ufferfilge, Jonathan G Matrisciano, Jonathan W Chapman, Joseph W Matthews, Junho Pak, Kathleen M Jordan, Kenneth Gordon, Kenneth M Gordon, Kenneth Nieves, Ko U Min, Kristina J Donohue, Kristina L Conroy, Lawrence Harmon, Jr, LCDR Susan E Polifko, Lori S Lawless, Marcellinus D Dordunoo, Marcus A Ray, Margaret M Doherty, Matthew M Henciak, Melissa J Garcia, Michael L Casner, Michael Serrano, Michael Shanks, MS, Mindy M Chou, Nebil A Oumer, Nicholas A Violand, Nicola M Fenty Stewart, Nicole E Knowlton, Paul L Bellamy, Rachael O Oyewole, Rachael Oyewole, Rachel C Harrington, Robert J Martin, Samantha J Bradley, Sharon K Thoma, PharmD, Shirshendu K Deb, PhD, Simone E Pitts, Srinivas R Chennamaneni, PhD, Thomas J Arista, Tonia F Bernard, Toyin B Oladimeji, Ucheabuchi C Chudi Nwankwor, Viviana Matta, Vivin George, Walter L Fava, Wanda Y Honeyblue, Yvesna C Blaise, Yvins Dezan, Zhongren Wu

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more